Skip to main content
logo
Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
62.90
0.00 (0.00%)
Sep 2, 2026, 5:29 PM CET

STO:IBT.B Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--00.080.01-
Revenue Growth
---94.80%541.67%--
Gross Profit
--00.080.01-
Operating Income
-84.98-69-145.34-134.62-65.81-44.67
Net Income
-81.92-65.17-136.91-123.07-65.45-44.99
Earnings Per Share
-6.08-4.84-10.16-9.95-5.83-4.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
108.6144.01223.39329.06335.84386.75
Net Cash Growth
-38.41%-35.53%-32.11%-2.02%-13.16%-8.66%
Net Cash Per Share
8.0610.6916.5826.6129.9234.45
Cash & Investments
108.6144.01223.39329.06335.84386.75

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-64.07-72.34-113.13-101.22-85.8-55.62
Capital Expenditures
------
Free Cash Flow
-64.07-72.34-113.13-101.22-85.8-55.62
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--100.00%100.00%100.00%-
Operating Margin
---3633575.00%-174827.27%-548400.00%-
Pretax Margin
---3422625.00%-159828.57%-545425.00%-
Profit Margin
---3422625.00%-159828.57%-545425.00%-
FCF Margin
---2828325.00%-131453.25%-714958.33%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--180517.0315745.8246775.77-